Ob.Gyn. NewsNew HER2-testing guidelines result in more women eligible for HER2-directed treatmentJuly 25, 2016Breast Cancer
Ob.Gyn. NewsI-SPY 2 graduates two neoadjuvant treatments to phase III trialsJuly 6, 2016Breast Cancer
Ob.Gyn. NewsIn-person, telephone genetic counseling yield similar outcomesJune 20, 2016Gynecologic CancerBreast CancerPreventive Care
Ob.Gyn. NewsAdjuvant AI therapy for breast cancer: 10 years is superior to 5 yearsJune 11, 2016Breast Cancer
Ob.Gyn. NewsVIDEO: Direct-to-patient study empowers patients, accelerates researchJune 7, 2016Breast Cancer
OBG ManagementWebcast: Oral contraceptives and breast cancer: What’s the risk?June 6, 2016Breast CancerContraceptionGynecologic CancerGynecology
Ob.Gyn. NewsHigh ER expression + high RS spells high risk for late distant recurrenceMay 23, 2016Breast Cancer